Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough



Rating:

Share or cite this content

Citations should be made in the following way:
N. Toledo Pons (Palma, Spain), J. Van Boven (Groningen, Netherlands), J. Muncunill (Palma, Spain), A. Millán Pons (Palma, Spain), M. Román-Rodríguez (Palma, Spain), B. López-Andrade (Palma, Spain), C. Almonacid (Madrid, Spain), D. Velasco Álvarez (Madrid, Spain), J. Kocks (Groningen, Netherlands), B. Cosío (Palma, Spain). Impact of blood eosinophil variability in asthma: a real-life population study.. 3116

Member's Comments

No comment yet.

Related content which might interest you: Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Characteristics of children with asthma and blood eosinophilia: an observational study Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Lack of seasonal variability of blood eosinophil counts in COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis Source: Eur Respir J, 59 (1) 2004590; 10.1183/13993003.04590-2020 Year: 2022 Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Determinants of blood eosinophil count in adults from a large population-based study Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Impact of the eosinophil variability on severe exacerbations in an asthmatic population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Real-world effectiveness of omalizumab in allergic asthma patients with low or high blood eosinophils: A retrospective claims analysis study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Stability of blood eosinophils over time in patients with asthma Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study Source: Eur Respir J, 51 (5) 1702523; 10.1183/13993003.02523-2017 Year: 2018 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Peripheral blood eosinophil counts in COPD patients and its relationship with prescription of inhaled corticosteroid in real world setting in Japan. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Response to omalizumab treatment according to blood eosinophil count: Results of a French real-world study (STELLAIR) Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Blood eosinophils in COPD: long term variability and clinical outcomes Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Characterisation of UK and US COPD populations in reference to exacerbation frequency and blood eosinophils level Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Blood eosinophils fluctuation in asthmatics on Omalizumab-a mirror of disease outcomes improvement? Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Longitudinal measurements of blood eosinophils in relation to COPD outcomes Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Blood neutrophil pattern is associated with poor asthma control in adults from the EGEA study Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study Source: Eur Respir J 2016; 48: 1040-1051 Year: 2016 Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients. Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021